GoAI
Get started
Diversified Healthcare Trust logo

Diversified Healthcare Trust

DHC

NASDAQReal EstateREIT - Healthcare Facilities

Open in GoAI

Previous close

$8.02

−$0.05 · -0.62%

Aug 21, 4:00 PM ET

DHC company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 1, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

53

Fair Value

Momentum

67

Gaining

Sentiment

59

Mixed

Risk resilience

56

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Diversified Healthcare Trust (DHC) operates as a real estate investment trust (REIT) specializing in healthcare properties. Its extensive portfolio comprises medical office buildings, life science facilities, senior living communities, and wellness centers located across the United States. DHC's management is provided by an operating subsidiary of The RMR Group Inc., an alternative asset management company headquartered in Newton, Massachusetts.

Industry
REIT - Healthcare Facilities
Sector
Real Estate
Headquarters
US
CEO
Christopher J. Bilotto
Listed since
Feb 23, 2000
Employees
600

Market position

Day range

Current $8.02

52-week range

Current $8.02

Open
$8.09
Previous close
$8.07
Volume
964.67K
0.56× average
Average volume
1.72M
Average daily volume
Market cap
1.94B USD
Beta
2.31
Market reference 1
50-day average
$8.9032
-9.92% below average
200-day average
$7.0542
+13.69% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
3.46B USD
P/E (TTM)
-7.24×
P/B (TTM)
1.22×
P/S (TTM)
1.29×
EV / EBITDA
18.99×
Earnings yield
-24.53%
Free cash flow yield
-1.68%
Dividend yield
0.50%

Profitability & efficiency

Gross margin
-5.25%
Operating margin
-2.08%
Net margin
-17.73%
Return on equity
-17.16%
Return on assets
-6.56%
Return on invested capital
-0.90%

Financial health

Debt / equity
1.53×
Current ratio
100.72×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends26%7%-11%-29%Gross margin, FY2021: 21.07%Gross margin, FY2022: 13.59%Gross margin, FY2023: 15.98%Gross margin, FY2024: 17.14%Gross margin, FY2025: -15.95%Operating margin, FY2021: -1.00%Operating margin, FY2022: -7.11%Operating margin, FY2023: 14.12%Operating margin, FY2024: 15.37%Operating margin, FY2025: -2.55%Net margin, FY2021: 12.62%Net margin, FY2022: -1.23%Net margin, FY2023: -20.82%Net margin, FY2024: -24.76%Net margin, FY2025: -18.59%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 21.07%. Gross margin FY2022 13.59%. Gross margin FY2023 15.98%. Gross margin FY2024 17.14%. Gross margin FY2025 -15.95%. Operating margin FY2021 -1.00%. Operating margin FY2022 -7.11%. Operating margin FY2023 14.12%. Operating margin FY2024 15.37%. Operating margin FY2025 -2.55%. Net margin FY2021 12.62%. Net margin FY2022 -1.23%. Net margin FY2023 -20.82%. Net margin FY2024 -24.76%. Net margin FY2025 -18.59%.

Income trends

Revenue

1.54B USD+2.84%

Operating income

−39.27M USD−269.13M USD

Net income

−285.89M USD+22.79%
Income trends across reported periods1.73B USD965.42M USD202.18M USD−561.07M USDRevenue, FY2021: 1.38B USDRevenue, FY2022: 1.28B USDRevenue, FY2023: 1.41B USDRevenue, FY2024: 1.5B USDRevenue, FY2025: 1.54B USDOperating income, FY2021: −13.82M USDOperating income, FY2022: −91.22M USDOperating income, FY2023: 199.17M USDOperating income, FY2024: 229.86M USDOperating income, FY2025: −39.27M USDNet income, FY2021: 174.52M USDNet income, FY2022: −15.77M USDNet income, FY2023: −293.57M USDNet income, FY2024: −370.26M USDNet income, FY2025: −285.89M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.38B USD. Revenue FY2022 1.28B USD. Revenue FY2023 1.41B USD. Revenue FY2024 1.5B USD. Revenue FY2025 1.54B USD. Operating income FY2021 −13.82M USD. Operating income FY2022 −91.22M USD. Operating income FY2023 199.17M USD. Operating income FY2024 229.86M USD. Operating income FY2025 −39.27M USD. Net income FY2021 174.52M USD. Net income FY2022 −15.77M USD. Net income FY2023 −293.57M USD. Net income FY2024 −370.26M USD. Net income FY2025 −285.89M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue1.54B USD1.5B USD1.41B USD1.28B USD1.38B USD
Cost of goods sold1.78B USD1.24B USD1.19B USD1.11B USD1.09B USD
Gross profit−245.33M USD256.38M USD225.3M USD174.5M USD291.4M USD
Selling, general, and administrative45.5M USD26.52M USD26.13M USD26.44M USD34.09M USD
Operating expenses−206.07M USD26.52M USD26.13M USD265.72M USD305.22M USD
Interest income—8.95M USD15.54M USD15.93M USD20.64M USD
Interest expense204.5M USD235.24M USD191.78M USD209.38M USD255.76M USD
Depreciation and amortization261.92M USD285.06M USD283.84M USD239.53M USD271.13M USD
Operating income−39.27M USD229.86M USD199.17M USD−91.22M USD−13.82M USD
Net income−285.89M USD−370.26M USD−293.57M USD−15.77M USD174.52M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
36%
4 beats, 7 misses, 0 met estimates
Average EPS surprise
+25.24%
11 comparable reports
Latest EPS result
-0.16
Estimate -0.15 · Miss by 9.09%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.13-0.05-0.22-0.4Q1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual -0.36, estimate -0.29, surprise -24.14%, Miss. Q2 2025, reported May 5, 2025: actual 0.06, estimate -0.25, surprise +124.00%, Beat. Q3 2025, reported Aug 4, 2025: actual 0.08, estimate -0.22, surprise +136.36%, Beat. Q4 2025, reported Nov 3, 2025: actual 0.04, estimate -0.215, surprise +118.60%, Beat. Q1 2026, reported Feb 23, 2026: actual 0.09, estimate -0.175, surprise +151.43%, Beat. Q2 2026, reported May 4, 2026: actual -0.18, estimate -0.157, surprise -14.89%, Miss. Q3 2026, reported Aug 3, 2026: actual -0.16, estimate -0.147, surprise -9.09%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate -0.15, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates408.6M388.96M369.32M349.67MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26MissQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 25, 2025: actual 379.62M USD, estimate 370.97M USD, surprise +2.33%, Beat. Q2 2025, reported May 5, 2025: actual 386.86M USD, estimate 383.17M USD, surprise +0.97%, Beat. Q3 2025, reported Aug 4, 2025: actual 382.71M USD, estimate 380.62M USD, surprise +0.55%, Beat. Q4 2025, reported Nov 3, 2025: actual 388.71M USD, estimate 382.31M USD, surprise +1.67%, Beat. Q1 2026, reported Feb 23, 2026: actual 379.57M USD, estimate 392.89M USD, surprise -3.39%, Miss. Q2 2026, reported May 4, 2026: actual 366.47M USD, estimate 380.18M USD, surprise -3.61%, Miss. Q3 2026, reported Aug 3, 2026: actual 365.39M USD, estimate 370.76M USD, surprise -1.45%, Miss. Q4 2026, reported Nov 2, 2026: actual —, estimate 370.87M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$9.25

15.34% upside
Past 12 months12-month forecastHigh $10.50Average $9.25Low $8.00

DHC news

seekingalpha.com

Diversified Healthcare Trust: A Cautious Buy

Diversified Healthcare Trust is rated 'Buy' as fundamentals and balance sheet have improved despite recent share price gains. Q2 2026 saw SHOP NOI up 37.2% YoY and margin expansion, with normalized FFO surging 109.4% to…

Read source
defenseworld.net

Diversified Healthcare Trust $DHC Shares Bought by Bank of America Corp DE

Bank of America Corp DE raised its stake in shares of Diversified Healthcare Trust (NASDAQ: DHC) by 90.4% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and…

Read source
defenseworld.net

Diversified Healthcare Trust (NASDAQ:DHC) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Diversified Healthcare Trust (NASDAQ: DHC - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six ratings firms that are currently covering the company, MarketBeat.com reports. One…

Read source
defenseworld.net

Dimensional Fund Advisors LP Purchases 138,708 Shares of Diversified Healthcare Trust $DHC

Dimensional Fund Advisors LP grew its holdings in shares of Diversified Healthcare Trust (NASDAQ: DHC) by 6.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange…

Read source
seekingalpha.com

Diversified Healthcare Trust (DHC) Q2 2026 Earnings Call Transcript

Diversified Healthcare Trust (DHC) Q2 2026 Earnings Call Transcript

Read source
marketbeat.com

Diversified Healthcare Trust Q2 Earnings Call Highlights

Diversified Healthcare Trust NASDAQ: DHC reported second-quarter results marked by higher senior housing profitability, continued occupancy and pricing gains, and reduced leverage, while reaffirming the full-year…

Read source

DHC peers

Equinix, Inc. logo

EQIX

Equinix, Inc.

$1,065.39

-1.59%

SBA Communications Corporation logo

SBAC

SBA Communications Corporation

$182.59

+1.14%

Host Hotels & Resorts, Inc. logo

HST

Host Hotels & Resorts, Inc.

$23.21

+0.52%

Lamar Advertising Company logo

LAMR

Lamar Advertising Company

$150.77

-0.16%

Regency Centers Corporation logo

REG

Regency Centers Corporation

$76.06

-0.59%

CoStar Group, Inc. logo

CSGP

CoStar Group, Inc.

$32.26

0.00%

ETFs holding DHC

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Real Estate ETF logoVanguard Real Estate ETFVNQ
Market value
67.62M
Weight
0.09%
AUM
73.1B USD
Expense ratio
0.13%
Price / 1D
$98.50-0.10%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
62.21M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
46.45M
Weight
0.06%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
22.32M
Weight
0.02%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
16.88M
Weight
0.12%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
Schwab U.S. REIT ETF logoSchwab U.S. REIT ETFSCHH
Market value
13.79M
Weight
0.12%
AUM
11.39B USD
Expense ratio
0.07%
Price / 1D
$24.04-0.08%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
11.15M
Weight
0.06%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
Schwab Fundamental U.S. Small Company Index ETF logoSchwab Fundamental U.S. Small Company Index ETFFNDA
Market value
10.83M
Weight
0.12%
AUM
9.26B USD
Expense ratio
0.25%
Price / 1D
$37.73+0.75%

Continue in GoAI

Research DHC

research.disclaimer